- Home
- PAA vs NBIX Comparison
PAA vs NBIX Comparison
Compare PAA & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAA
- NBIX
- Stock Information
- Founded
- PAA 1981
- NBIX 1992
- Country
- PAA United States
- NBIX United States
- Employees
- PAA N/A
- NBIX N/A
- Industry
- PAA Natural Gas Distribution
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PAA Energy
- NBIX Health Care
- Exchange
- PAA Nasdaq
- NBIX Nasdaq
- Market Cap
- PAA 12.1B
- NBIX 12.2B
- IPO Year
- PAA N/A
- NBIX 1996
- Fundamental
- Price
- PAA $18.32
- NBIX $126.59
- Analyst Decision
- PAA Buy
- NBIX Strong Buy
- Analyst Count
- PAA 13
- NBIX 20
- Target Price
- PAA $20.67
- NBIX $163.20
- AVG Volume (30 Days)
- PAA 3.4M
- NBIX 857.9K
- Earning Date
- PAA 08-01-2025
- NBIX 07-31-2025
- Dividend Yield
- PAA 8.30%
- NBIX N/A
- EPS Growth
- PAA N/A
- NBIX N/A
- EPS
- PAA 0.93
- NBIX 2.96
- Revenue
- PAA $50,089,000,000.00
- NBIX $2,412,600,000.00
- Revenue This Year
- PAA N/A
- NBIX $16.29
- Revenue Next Year
- PAA $18.70
- NBIX $15.08
- P/E Ratio
- PAA $19.67
- NBIX $42.60
- Revenue Growth
- PAA 3.56
- NBIX 21.73
- 52 Week Low
- PAA $15.58
- NBIX $84.23
- 52 Week High
- PAA $21.00
- NBIX $157.98
- Technical
- Relative Strength Index (RSI)
- PAA 60.83
- NBIX 60.49
- Support Level
- PAA $17.61
- NBIX $123.04
- Resistance Level
- PAA $18.64
- NBIX $128.38
- Average True Range (ATR)
- PAA 0.43
- NBIX 2.79
- MACD
- PAA 0.05
- NBIX -0.26
- Stochastic Oscillator
- PAA 60.61
- NBIX 67.50
About PAA Plains All American Pipeline L.P.
Plains All American Pipeline LP through its subsidiaries, engages in the pipeline transportation, terminaling, storage, and gathering of crude oil and natural gas liquids (NGL) in the United States and Canada. The company operates through two segments, Crude Oil and NGL. The Crude Oil segment offers gathering and transporting crude oil through pipelines, gathering systems, trucks, and barges or railcars. The NGL segment is involved in natural gas processing and NGL fractionation, storage, transportation, and terminalling. It generates the majority of its revenue from the Crude Oil segment.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.